GlassScriptPhysician profile
Michael H Schlesinger
NPI 1922086966
$13,254.44
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,515 · 2020: $2,615 · 2021: $1,214 · 2022: $1,516 · 2023: $4,377 · 2024: $16.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,936 · Consulting Fee: $1,166 · Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,935.75 |
| Consulting Fee | $1,166.00 |
| Food and Beverage | $292.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $6,027.70 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $4,973.26 | 2019-2022 | |
| Neotract INC. | $770.58 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $305.78 | 2019-2022 | |
| Abbvie INC. | $275.08 | 2019-2022 | |
| Pfizer INC. | $182.97 | 2019-2022 | |
| Antares Pharma, INC. | $120.76 | 2019-2022 | |
| Urovant Sciences INC | $100.78 | 2021-2022 | |
| Coloplast Corp | $86.37 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $77.90 | 2022 | |
| Teleflex LLC | $56.09 | 2021-2022 | |
| Janssen Biotech, INC. | $52.83 | 2020-2022 | |
| Boston Scientific Corporation | $47.60 | 2020-2022 | |
| Procept Biorobotics Corporation | $39.26 | 2019 | |
| Medtronic, INC. | $30.59 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $20.10 | 2021 | |
| Travere Therapeutics, INC. | $18.87 | 2020 | |
| Medtronic USA, INC. | $16.11 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.18 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.14 | 2019 | |
| Acerus Pharmaceuticals Corporation | $12.00 | 2022 | |
| Allergan, INC. | $11.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schlesinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.